- In-depth review
-
항생제 사용관리 프로그램의 국내 실행을 위한 핵심요소 -종합병원대상-
-
Hae Suk Cheong, Kyung-Hwa Park, Hong Bin Kim, Shin-Woo Kim, Bongyoung Kim, Chisook Moon, Mi Suk Lee, Young Kyung Yoon, Su Jin Jeong, Yong Chan Kim, Byung Wook Eun, Hyukmin Lee, Ji-Yeon Shin, Hyung-sook Kim, In Sun Hwang, Choon-Seon Park, Ki Tae Kwon, Korean Society for Antimicrobial Therapy, The Korean Society of Infectious Diseases, Korean Society for Healthcare-associated Infection Control and Prevention, Korean Society of Pediatric Infectious Diseases, Korean Society of Health-System Pharmacists
-
Korean J Med. 2023;98(1):11-39. Published online February 1, 2023
-
-
Full text PubReader ePub PDF
- 소화기 / Original Article
-
약제 내성 만성 B형 간염 환자에서 S202, M250 엔테카비어 내성이 테노포비어 근간 구제 요법의 바이러스 반응에 미치는 영향
-
Sung Eun Kim, Ji Won Park, Hyoung Su Kim, Ki Tae Suk, Myoung Kuk Jang, Sang Hoon Park, Myung Seok Lee, Dong Joon Kim, Choong Kee Park
-
Korean J Med. 2015;89(5):527-536. Published online November 1, 2015
-
-
Full text PubReader ePub PDF
- 감염 / Special Review
-
다제내성 그람음성균 감염의 항생제 치료
-
Cheol-In Kang
-
Korean J Med. 2015;88(5):502-508. Published online May 1, 2015
-
-
PDF
- Original Article
-
라미부딘 내성 만성 B형 간염 환자에서 라미부딘과 아데포비어 병용치료
-
Hyun Seok Lee, Soo Young Park, So Young Choi, Min Kyu Jung, Seong Woo Jeon, Chang Min Cho, Young Oh Kweon, Sung Kook Kim, Yong Hwan Choi, Won Young Tak
-
Korean J Med. 2009;77(6):716-722.
-
-
PDF
- Original Article
-
만성 B형 간염 치료
-
Jung Woo Shin, Neung Hwa Park
-
Korean J Med. 2009;77(3):265-274.
-
-
PDF
- Original Article
-
시프로프록사신에 반응하지 않은 해외유입 장티푸스 3예
-
Dae-Bum Kim, Si-Hyun Kim, Su-Jin Oh, Dong Kyu Kim, Su-Mi Choi, Myungshin Kim, Wan-Shik Shin
-
Korean J Med. 2009;77(3):377-381.
-
-
PDF
- Original Article
-
새로운 항생제의 개발
-
Mi Suk Lee
-
Korean J Med. 2009;77(1):35-51.
-
-
PDF
- Original Article
-
원저 : 치료력이 없는 HIV 감염환자에서 약제내성 빈도
-
Seo Rin Kim, Eun Kyung Rheu, Young Mi Seol, Dong Heuck Cha, Su Jin Lee, Yeun Kyung Yoon, Soon Mi Park, Heyung Hoe Kim, Hak Sun Rheu, Soon Chul Ahn, Sun Hee Lee, Im Su Kwak, Goon Jae Cho
-
Korean J Med. 2007;73(3):243-250.
-
-
PDF
|